These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

421 related items for PubMed ID: 19000540

  • 1. Multicenter prospective randomized, double-blind comparative study between lanthanum carbonate and calcium carbonate as phosphate binders in Japanese hemodialysis patients with hyperphosphatemia.
    Shigematsu T, Lanthanum Carbonate Group.
    Clin Nephrol; 2008 Nov; 70(5):404-10. PubMed ID: 19000540
    [Abstract] [Full Text] [Related]

  • 2. Lanthanum carbonate effectively controls serum phosphate without affecting serum calcium levels in patients undergoing hemodialysis.
    Shigematsu T, Lanthanum Carbonate Research Group.
    Ther Apher Dial; 2008 Feb; 12(1):55-61. PubMed ID: 18257813
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of Treating Hyperphosphatemia With Lanthanum Carbonate vs Calcium Carbonate on Cardiovascular Events in Patients With Chronic Kidney Disease Undergoing Hemodialysis: The LANDMARK Randomized Clinical Trial.
    Ogata H, Fukagawa M, Hirakata H, Kagimura T, Fukushima M, Akizawa T, LANDMARK Investigators and Committees.
    JAMA; 2021 May 18; 325(19):1946-1954. PubMed ID: 34003226
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Long-term efficacy and tolerability of lanthanum carbonate: results from a 3-year study.
    Hutchison AJ, Maes B, Vanwalleghem J, Asmus G, Mohamed E, Schmieder R, Backs W, Jamar R, Vosskühler A.
    Nephron Clin Pract; 2006 May 18; 102(2):c61-71. PubMed ID: 16224198
    [Abstract] [Full Text] [Related]

  • 11. Study of prolonged administration of lanthanum carbonate in dialysis patients.
    Gotoh J, Kukita K, Tsuchihashi S, Hattori M, Iida J, Horie T, Onodera K, Furui H, Tamaki T, Meguro J, Yonekawa M, Kawamura A.
    Ther Apher Dial; 2013 Apr 18; 17 Suppl 1():9-14. PubMed ID: 23586507
    [Abstract] [Full Text] [Related]

  • 12. Three-year follow-up of lanthanum carbonate therapy in hemodialysis patients.
    Takeuchi K, Matsuda E, Sekino M, Hasegawa Y, Kamo Y, Kikuchi N, Sekino H.
    Ther Apher Dial; 2013 Apr 18; 17 Suppl 1():15-21. PubMed ID: 23586508
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical effects of long-term (36-month) lanthanum carbonate administration in hemodialysis patients in Japan.
    Kishi Y, Obara Y, Hara K, Yamashiro H, Kurosawa N, Takada D.
    Ther Apher Dial; 2014 Jun 18; 18 Suppl 1():9-13. PubMed ID: 24953760
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Design and baseline characteristics of the LANDMARK study.
    Ogata H, Fukagawa M, Hirakata H, Kaneda H, Kagimura T, Akizawa T, LANDMARK Study Group.
    Clin Exp Nephrol; 2017 Jun 18; 21(3):531-537. PubMed ID: 27405619
    [Abstract] [Full Text] [Related]

  • 20. Effect of lanthanum carbonate vs. calcium carbonate on serum calcium in hemodialysis patients: a crossover study.
    Toida T, Fukudome K, Fujimoto S, Yamada K, Sato Y, Chiyotanda S, Kitamura K.
    Clin Nephrol; 2012 Sep 18; 78(3):216-23. PubMed ID: 22874110
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.